Mountain Cedar Pollen Allergy: The Winter Hay Fever of the Southwest

Cedar fever is the colloquial name for the severe allergic reaction to mountain cedar pollen that occurs in central Texas and surrounding areas during December–February. It mimics influenza with symptoms including intense fatigue, nasal congestion, headache, and body aches, but it does NOT cause an actual fever. The term 'fever' refers to the sensation of feeling feverish, not an elevated body temperature. If you have a measured temperature above 100.4°F, you likely have a viral illness, not cedar fever. The distinction is important because cedar fever is treated with antihistamines and nasal steroids, not antivirals or antibiotics. A board-certified allergist can help confirm the diagnosis with allergy testing.

No, they are different species within the same genus. Mountain cedar is Juniperus ashei, native to the Edwards Plateau of Texas, Oklahoma, and northern Mexico. Eastern red cedar is Juniperus virginiana, which is widespread across the eastern United States. Both are wind-pollinated junipers in the Cupressaceae family, and their major allergens (Jun a 1 and Jun v 1) are highly cross-reactive. Patients sensitized to one may react to the other. However, the pollination seasons differ slightly: mountain cedar peaks in December–January, while Eastern red cedar peaks in January–March. The intensity of mountain cedar pollen counts in central Texas is generally much higher than Eastern red cedar counts in the eastern US.

Yes, mountain cedar pollen is a well-documented trigger for asthma exacerbations. The small particle size (20–30 microns) allows pollen to penetrate the lower airways, and the intense inflammatory response can trigger bronchoconstriction in patients with allergic asthma. Studies from the Texas Hill Country have shown that emergency department visits for asthma increase by 30–50% during the mountain cedar pollen season. Patients with known asthma who live in or travel to endemic areas during December–February should have a pre-season asthma action plan in place, including optimized controller medications and a clear protocol for worsening symptoms. If you experience wheezing, chest tightness, or difficulty breathing, seek emergency care immediately.

The primary mountain cedar pollen season typically runs from mid-December through February, with a sharp peak in late December and early January. The exact timing and duration depend on weather patterns: cold fronts trigger explosive pollen release, and prolonged cold weather can extend the season into early March. In most years, pollen counts decline significantly by mid-February and return to baseline by early March. However, the season can vary by 2–4 weeks depending on the specific weather patterns of a given year. Patients in endemic areas should monitor local pollen counts through the National Allergy Bureau or local weather services to track the season's progression.

There is no cure for mountain cedar pollen allergy, but allergen immunotherapy (allergy shots or sublingual drops) is the only disease-modifying treatment that can induce long-term immune tolerance. Immunotherapy works by gradually exposing the immune system to increasing doses of mountain cedar pollen extract, training it to become less reactive over time. Clinical trials show that 60–80% of patients experience significant symptom reduction after completing a 3–5 year course of immunotherapy. The benefits often persist for years after treatment ends. For patients who are not candidates for or choose not to pursue immunotherapy, pharmacotherapy with intranasal corticosteroids and antihistamines provides effective symptom control but does not alter the underlying allergic sensitivity.

Yes, new-onset mountain cedar pollen allergy can develop at any age, including adulthood. The mechanism is the same regardless of age: repeated exposure to high concentrations of Jun a 1 pollen in a genetically susceptible individual can eventually drive IgE sensitization and symptomatic allergic rhinitis. Adults who relocate to central Texas and experience their first winter respiratory symptoms after the move may be developing new sensitization to mountain cedar driven by the extraordinarily high pollen counts they did not experience previously. This clinical presentation — 'I never had allergies before I moved to Austin' — is common and should prompt evaluation with a regional pollen panel by a board-certified allergist.

Mountain cedar (Juniperus ashei) and Japanese cedar (Cryptomeria japonica) are different tree species in the Cupressaceae family, but their major allergens — Jun a 1 and Cry j 1 — are both pectate lyases with high structural homology. This means that patients sensitized to one may show cross-reactive IgE responses to the other. The clinical significance of this cross-reactivity is that a patient with mountain cedar allergy who travels to Japan during the Japanese cedar season (February–April) may experience symptoms, and vice versa. However, the pollen seasons and geographic distributions are distinct: mountain cedar is endemic to Texas and Oklahoma, while Japanese cedar is endemic to Japan. Immunotherapy with one species may provide some cross-protection against the other, though this is not guaranteed.

Yes, untreated mountain cedar pollen allergy is a significant risk factor for developing acute bacterial sinusitis. The intense nasal inflammation and mucosal swelling caused by the allergic response can obstruct the sinus ostia — the small openings that drain the sinuses. When these openings are blocked, mucus accumulates in the sinus cavities, creating a stagnant environment that favors bacterial overgrowth. Patients with cedar fever who develop purulent (yellow or green) nasal discharge, facial pain or pressure, fever, and worsening headache after the first week of symptoms should be evaluated for secondary bacterial sinusitis. Treatment typically requires antibiotics in addition to continued allergy management. Preventing sinusitis starts with controlling the underlying allergic inflammation with intranasal corticosteroids and antihistamines.

The tendency to develop IgE-mediated allergies in general has a strong genetic component, but there is no specific 'mountain cedar allergy gene.' Atopy — the genetic predisposition to produce IgE antibodies in response to environmental allergens — is inherited and increases the risk of developing allergic rhinitis, asthma, and eczema. A family history of any allergic condition increases the likelihood that an individual will develop sensitization to mountain cedar if they are exposed to high pollen counts. However, the specific allergens to which a person becomes sensitized are influenced by environmental exposure, not genetics alone. A person with a strong family history of atopy who moves to central Texas is at higher risk of developing mountain cedar allergy than someone without that genetic predisposition.

There are no specific medications that are contraindicated solely because of a mountain cedar pollen allergy. However, patients should be aware that some over-the-counter 'cold and flu' combination products contain multiple active ingredients that may not be appropriate for their symptoms. For example, products containing decongestants (pseudoephedrine, phenylephrine) should be used with caution in patients with high blood pressure, heart conditions, or glaucoma. First-generation antihistamines (diphenhydramine/Benadryl) cause significant drowsiness and should be avoided during daytime hours, especially if driving or operating machinery. The safest approach is to use single-ingredient medications as recommended by your allergist: intranasal corticosteroids as first-line therapy, second-generation antihistamines for sneezing and itching, and saline irrigation for nasal cleansing. Always consult your allergist or pharmacist before starting any new medication.